ACCURUN 119 ANTI-HEPATITIS B E ANTIGEN (ANTI-HBE) POSITIVE CONTROL

Multi-analyte Controls, All Kinds (assayed)

BOSTON BIOMEDICA, INC.

The following data is part of a premarket notification filed by Boston Biomedica, Inc. with the FDA for Accurun 119 Anti-hepatitis B E Antigen (anti-hbe) Positive Control.

Pre-market Notification Details

Device IDK972307
510k NumberK972307
Device Name:ACCURUN 119 ANTI-HEPATITIS B E ANTIGEN (ANTI-HBE) POSITIVE CONTROL
ClassificationMulti-analyte Controls, All Kinds (assayed)
Applicant BOSTON BIOMEDICA, INC. 375 WEST ST. West Bridgewater,  MA  02379
ContactPatricia E Garrett
CorrespondentPatricia E Garrett
BOSTON BIOMEDICA, INC. 375 WEST ST. West Bridgewater,  MA  02379
Product CodeJJY  
CFR Regulation Number862.1660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1997-06-19
Decision Date1997-08-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.